Evercore Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $680

Evercore维持麦克森(MCK.US)买入评级，上调目标价至680美元

moomoo资讯 · 11/07 08:39 · 评级/大行评级

Evercore analyst Elizabeth Anderson CFA maintains $McKesson (MCK.US)$ with a buy rating, and adjusts the target price from $630 to $680.

According to TipRanks data, the analyst has a success rate of 38.0% and a total average return of -8.0% over the past year.

AnalystRecentRatingAutoNews_201851_20241107_6a8f23bc048d784b18332e579f16f374da6379f3_1730986284959530_mm_en

Furthermore, according to the comprehensive report, the opinions of $McKesson (MCK.US)$'s main analysts recently are as follows:

The stock experienced a 5% increase following results that challenged the prevailing skeptical view on the company's long-term target potential.
The firm observed that McKesson's performance was robust across all segments, with particularly strong second-quarter results in US Pharma. Additionally, the implication from the guidance's midpoint suggesting an acceleration in segment EBIT during FY25 was found to be encouraging.
McKesson has addressed several issues and mitigated some significant concerns. The company, along with its peers, has consistently delivered strong updates. Large-cap healthcare currently appears to be somewhat undervalued and not as widely held. It's challenging to find a compelling reason why the company would not revert to its recently higher valuation multiples.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

Evercore分析师Elizabeth Anderson CFA维持$麦克森 (MCK.US)$买入评级，并将目标价从630美元上调至680美元。

根据TipRanks数据显示，该分析师近一年总胜率为38.0%，总平均回报率为-8.0%。

AnalystRecentRatingAutoNews_201851_20241107_6a8f23bc048d784b18332e579f16f374da6379f3_1730986284959530_mm_sc

此外，综合报道，$麦克森 (MCK.US)$近期主要分析师观点如下：

该股票在挑战了长期目标潜力的普遍怀疑观念之后，经历了5%的增长。
公司观察到麦克森在所有板块表现强劲，特别是在美国制药板块取得了强劲的第二季度业绩。此外，指导中点意味着FY25期间部门EBIt加速增长的暗示被认为是鼓舞人心的。
麦克森已经解决了一些问题并缓解了一些重要关切。该公司与同行一起，持续发布强劲的更新。大型医疗保健目前似乎被低估，且持有率不够广泛。很难找到一个令人信服的理由，解释为何该公司不会回归到最近更高的估值倍数。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Evercore Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $680

Evercore Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $680

风险及免责提示

声明